This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Cigna (CI) Rises 18.9% in 6 Months: More Growth in Store?
by Zacks Equity Research
Cigna (CI) expects its long-term adjusted earnings per share to witness 10-13% average annual growth.
Cigna (CI) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Should Invesco S&P 500 Pure Value ETF (RPV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for RPV
Is Invesco S&P 500 Pure Value ETF (RPV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RPV
Should IQ Chaikin U.S. Large Cap ETF (CLRG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for CLRG
Is IQ Chaikin U.S. Large Cap ETF (CLRG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for CLRG
Cigna (CI) Q3 Earnings Top on Evernorth Unit, 2022 EPS View Up
by Zacks Equity Research
Cigna's (CI) third-quarter results reflect strong pharmacy revenues coupled with solid segmental performances. A hiked 2022 EPS outlook is commendable.
MetLife (MET) Q3 Earnings Beat Estimates on Strong Volume Growth
by Zacks Equity Research
MetLife (MET) repurchases $674 million worth of shares during the third quarter.
Cigna (CI) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Cigna (CI) delivered earnings and revenue surprises of 5.96% and 1.10%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
MGIC Investment (MTG) Q3 Earnings Top Estimates
by Zacks Equity Research
MGIC (MTG) delivered earnings and revenue surprises of 56.36% and 8.11%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Can Cigna's (CI) Q3 Earnings Beat on Evernorth Performance?
by Zacks Equity Research
The third-quarter results of Cigna (CI) are likely to reflect a rise in total medical customers.
Is a Surprise Coming for Cigna (CI) This Earnings Season?
by Zacks Equity Research
Cigna (CI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
FS KKR Capital (FSK) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Solid improvement in total investment income on higher interest rates is likely to have supported FS KKR Capital's (FSK) Q3 earnings.
Cigna Corporation (CI) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Cigna (CI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Should Invesco S&P 500 GARP ETF (SPGP) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPGP
Cigna (CI) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Cigna (CI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cigna (CI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Cigna (CI) closed at $314.95 in the latest trading session, marking a +1.3% move from the prior day.
Here's Why Cigna (CI) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Cigna (CI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Amalgamated Financial (AMAL) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Amalgamated Financial (AMAL) and Cigna (CI) have performed compared to their sector so far this year.
Here's How Much a $1000 Investment in Cigna Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Are Investors Undervaluing Cigna (CI) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cigna (CI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $294.31, marking a +0.42% move from the previous day.
Zacks Investment Ideas feature highlights: Cigna
by Zacks Equity Research
Cigna has been highlighted in this Investment Ideas article.
Zacks Earnings ESP: A Better Way to Find Earnings Surprises for Finance
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Cigna (CI) Stock Moves -0.79%: What You Should Know
by Zacks Equity Research
Cigna (CI) closed at $295.30 in the latest trading session, marking a -0.79% move from the prior day.